Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Jan-Feb:33:101566.
doi: 10.1016/j.tmaid.2020.101566. Epub 2020 Jan 30.

SARS-CoV, MERS-CoV and now the 2019-novel CoV: Have we investigated enough about coronaviruses? - A bibliometric analysis

D Katterine Bonilla-Aldana  1 , Keidenis Quintero-Rada  2 , Juan Pablo Montoya-Posada  2 , Sebastian Ramírez-Ocampo  3 , Alberto Paniz-Mondolfi  4 , Ali A Rabaan  5 , Ranjit Sah  6 , Alfonso J Rodríguez-Morales  7
Affiliations
Comment

SARS-CoV, MERS-CoV and now the 2019-novel CoV: Have we investigated enough about coronaviruses? - A bibliometric analysis

D Katterine Bonilla-Aldana et al. Travel Med Infect Dis. 2020 Jan-Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest Alfonso J. Rodríguez-Morales attended as Expert Participant in The 2018 Annual Review of the WHO R&D Blueprint Priority List of Diseases, WHO HQ Avenue Appia 20, 1211 Geneva, 6th and 7th February 2018.

Figures

Fig. 1
Fig. 1
Scientific production on CoV. A. Trends in time, January 1996–January 2020 (SCI, Scopus and PubMed). B. Top ten countries in number of CoV-publications (SCI and Scopus). C. Distribution by different CoV research (SCI, Scopus and PubMed).
See this image and copyright information in PMC

Comment on

References

    1. Momattin H., Al-Ali A.Y., Al-Tawfiq J.A. A systematic review of therapeutic agents for the treatment of the Middle East respiratory syndrome coronavirus (MERS-CoV) Trav Med Infect Dis. 2019;30:9–18. - PMC - PubMed
    1. Cui J., Li F., Shi Z.L. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17:181–192. - PMC - PubMed
    1. World Health Organization List of Blueprint priority diseases. 2018. https://www.who.int/activities/prioritizing-diseases-for-research-and-de... URL:
    1. Leung G.M., Chung P.H., Tsang T., Lim W., Chan S.K., Chau P. SARS-CoV antibody prevalence in all Hong Kong patient contacts. Emerg Infect Dis. 2004;10:1653–1656. - PMC - PubMed
    1. Khan A., Farooqui A., Guan Y., Kelvin D.J. Lessons to learn from MERS-CoV outbreak in South Korea. J Infect Dev Ctries. 2015;9:543–546. - PubMed

MeSH terms